Search

Professor Axel Behrens

Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said that the approval of pembrolizumab (Keytruda) in combination with chemo for use on the NHS in Scotland was fantastic news.

Researchers are investigating the experiences of black African and Caribbean women taking hormone therapy and the challenges that come with taking the medication, thanks to funding from Breast Cancer Now.

After her diagnosis, Claire felt her choices had been taken away. But after volunteering with us and joining Breast Cancer Voices, Claire had a chance to have her say and play a part in breast cancer support.

Anjli uses her experience and skills to make sure that younger women of South Asian descent are represented in our work.

More people than ever before are living with and beyond breast cancer. We need to improve the quality of life for all those affected.

Shirley was diagnosed with secondary breast cancer in 2016, but sadly passed away in 2020. Her husband, Bob, tells us about how one of her last wishes was to meet her grandchild.

Following her breast cancer diagnosis, Rhakima is passionate about raising awareness within ethnic minority groups.

In response to the news abemaciclib has been approved by THE National Institute for Health and Care Excellence (NICE) for routine use on the NHS with hormone therapy, following surgery for certain women with hormone receptor positive, HER2 negative primary breast cancer, whose disease is lymph node positive, Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said:

Join one of our monthly online group sessions. They’re informal, relaxed and offer a space for you to talk about whatever’s on your mind.

A printable PDF catalogue listing all of our publications, with ordering instructions and QR code.

Dr Kotryna Temcinaite, Senior Research Communications Manager at Breast Cancer Now, said:

688 posts

579 posts

5 posts